1 unchanged sentence
Rule 10b5-1 Trading Plans
−Removed: During the quarter ended June 30, 2024, no director or executive officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
+Added: During the quarter ended September 30, 2024, no director or executive officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
Pacira BioSciences, Inc.
2 unchanged sentences
Exhibit Number Description
−Removed: Indenture, dated as of May 14, 2024, by and between the Registrant and Computershare Corporate Trust, National Association.(1)
−Removed: Form of Global 2.125% Convertible Senior Notes due 2029 (included in Exhibit 4.1).(1)
−Removed: First Amendment, dated as of May 8, 2024, to Credit Agreement, dated as of March 31, 2023, by and among Pacira BioSciences, Inc., the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent.(2)
−Removed: Form of Capped Call Transaction Confirmation.(1)
−Removed: Fifth Amendment to Consulting Agreement, dated June 12, 2024, between the Registrant and Gary Pace.***
+Added: Employment Agreement, dated April 19, 2012, between the Registrant and Lauren Riker.(1)***
+Added: Amendment No.
+Added: 1 to Employment Agreement, dated March 13, 2013, between the Registrant and Lauren Riker.(2)***
+Added: Amendment No.
+Added: 2 to Employment Agreement, dated June 30, 2015, between the Registrant and Lauren Riker.* ***
+Added: Amendment No.
+Added: 3 to Employment Agreement, dated August 16, 2024, between the Registrant and Lauren Riker.* ***
+Added: Non-Healthcare Professional Consulting Agreement, effective October 1, 2024, between the Registrant and Charles.
+Added: Reinhart, III* ***
+Added: Amended and Restated 2014 Inducement Plan.* ***
+Added: Form of Nonstatutory Stock Option Agreement under the Amended and Restated 2014 Inducement Plan.* ***
+Added: Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2014 Inducement Plan.* ***
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a), as amended.*
3 unchanged sentences
101 The following materials from the Quarterly Report on Form 10-Q of Pacira BioSciences, Inc.
−Removed: for the quarter ended June 30, 2024, formatted in iXBRL (Inline eXtensible Business Reporting Language):
+Added: for the quarter ended September 30, 2024, formatted in iXBRL (Inline eXtensible Business Reporting Language):
(i) the Condensed Consolidated Balance Sheets;
(ii) the Condensed Consolidated Statements of Operations;
−Removed: (iii) the Condensed Consolidated Statements of Comprehensive Income;
+Added: (iii) the Condensed Consolidated Statements of Comprehensive (Loss) Income;
(iv) the Condensed Consolidated Statements of Stockholders’ Equity;
5 unchanged sentences
*** Denotes management contract or compensatory plan or arrangement.
−Removed: + Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K.
−Removed: The Company hereby undertakes to supplementally furnish copies of any omitted schedules and exhibits to the Securities and Exchange Commission upon request.
−Removed: (1) Incorporated by reference to the Company’s Current Report on Form 8-K, filed on May 14, 2024.
−Removed: (2) Incorporated by reference to the Company’s Current Report on Form 8-K, filed on May 8, 2024.
+Added: (1) Incorporated by reference to the exhibits to the registrant's Quarterly Report on Form 10-Q, filed on May 9, 2012.
+Added: (2) Incorporated by reference to the exhibits to the registrant’s Current Report on Form 8-K, filed on March 18, 2013.
Pacira BioSciences, Inc.
2 unchanged sentences
PACIRA BIOSCIENCES, INC.
−Removed: July 30, 2024 By:
+Added: November 6, 2024 By:
Chief Executive Officer and Director
(Principal Executive Officer)
−Removed: July 30, 2024 By:
−Removed: /s/ CHARLES A.
−Removed: REINHART, III
−Removed: Reinhart, III
+Added: November 6, 2024 By:
Chief Financial Officer
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.